Page last updated: 2024-10-28

lidocaine and Cerebral Ischemia

lidocaine has been researched along with Cerebral Ischemia in 49 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Research Excerpts

ExcerptRelevanceReference
" To quantify effects of a loading dose of midazolam and lidocaine on the EEG frequency spectrum of full-term neonates with perinatal arterial ischemic stroke (PAIS), 11 full-term infants underwent multi-channel amplitude-integrated EEG (aEEG) and EEG recordings."7.78Effects of midazolam and lidocaine on spectral properties of the EEG in full-term neonates with stroke. ( Andriessen, P; Dankers, F; de Vries, L; Janssen, F; Jennekens, W; Niemarkt, H; Toet, M; van der Aa, N; van Pul, C, 2012)
"To study the protective effects of lidocaine and nerve growth factor (NGF) pretreatment on cerebral ischemia/reperfusion (I/R) injury."7.76[A study of the protective effects of lidocaine and nerve growth factor pretreatment on cerebral ischemia/reperfusion injury in gerbils]. ( Wang, DF; Xie, JD, 2010)
"The authors' previous study demonstrated that a clinical antiarrhythmic dose of lidocaine, when given before ischemia, is neuroprotective in a rat model of transient focal cerebral ischemia."7.71Effects of delayed administration of low-dose lidocaine on transient focal cerebral ischemia in rats. ( Capuano-Waters, C; Cottrell, JE; Kass, IS; Lei, B; Popp, S, 2002)
"We examined the effect of subarachnoid administration of lidocaine on delayed neuronal damage due to forebrain ischemia in rats."7.69[Subarachnoid administration of lidocaine reduces delayed neuronal damage due to forebrain ischemia in rats]. ( Mizunuma, T; Ohta, S; Suzuki, M, 1996)
"Dogs were treated with repeated doses of lidocaine or equivalent volumes of saline during hyperbaric therapy after internal carotid air embolism and transient hypertension."7.68Effect of lidocaine on somatosensory evoked response and cerebral blood flow after canine cerebral air embolism. ( Clark, JB; Dutka, AJ; Hallenbeck, JM; McDermott, J; Mink, R, 1992)
"We examined the effect of lidocaine on ischemic neuronal injury in the rat forebrain ischemia model."7.67Effect of lidocaine on forebrain ischemia in rats. ( Louw, D; Ong, BY; Sima, AA; Sutherland, G, 1989)
"Pretreatment with lidocaine also greatly attenuated the acute hypertension and the increase in intracranial pressure following air embolism."5.27Protective effect of lidocaine in acute cerebral ischemia induced by air embolism. ( Bradley, ME; Evans, DE; Kobrine, AI; LeGrys, DC, 1984)
"Cerebral ischemia was induced in dogs on cardiopulmonary bypass circulation by stopping the pump."5.26Increase in extracellular potassium in the brain during circulatory arrest: effects of hypothermia, lidocaine, and thiopental. ( Astrup, J; Gjerris, F; Skovsted, P; Sørensen, HR, 1981)
" To quantify effects of a loading dose of midazolam and lidocaine on the EEG frequency spectrum of full-term neonates with perinatal arterial ischemic stroke (PAIS), 11 full-term infants underwent multi-channel amplitude-integrated EEG (aEEG) and EEG recordings."3.78Effects of midazolam and lidocaine on spectral properties of the EEG in full-term neonates with stroke. ( Andriessen, P; Dankers, F; de Vries, L; Janssen, F; Jennekens, W; Niemarkt, H; Toet, M; van der Aa, N; van Pul, C, 2012)
"To study the protective effects of lidocaine and nerve growth factor (NGF) pretreatment on cerebral ischemia/reperfusion (I/R) injury."3.76[A study of the protective effects of lidocaine and nerve growth factor pretreatment on cerebral ischemia/reperfusion injury in gerbils]. ( Wang, DF; Xie, JD, 2010)
"The authors' previous study demonstrated that a clinical antiarrhythmic dose of lidocaine, when given before ischemia, is neuroprotective in a rat model of transient focal cerebral ischemia."3.71Effects of delayed administration of low-dose lidocaine on transient focal cerebral ischemia in rats. ( Capuano-Waters, C; Cottrell, JE; Kass, IS; Lei, B; Popp, S, 2002)
" To examine the mechanisms underlying these seizures, we determined the impact of prior forebrain ischemia on the seizure thresholds of four convulsants with differing modes of action: lidocaine, pentylenetetrazol (PTZ), N-methyl-D-aspartate (NMDA), and picrotoxin."3.70Forebrain ischemia: effect on pharmacologically induced seizure thresholds in the rat. ( Kim, DC; Todd, MM, 1999)
" Transient forebrain ischemia produced significant increase in aspartate, glutamate, glycine and taurine (760%, 1070%, 190% and 1210%, respectively), and neuronal blockade by perfusion with a lidocaine (4 mM)-containing medium resulted in 67%, 79%, 58% and 59% reduction in the peak values of each amino acid, respectively."3.69Lidocaine protects hippocampal neurons against ischemic damage by preventing increase of extracellular excitatory amino acids: a microdialysis study in Mongolian gerbils. ( Adachi, N; Arai, T; Fujitani, T; Kataoka, K; Liu, K; Miyazaki, H; Nakamura, Y, 1994)
" lidocaine in facilitating recovery from cerebral ischemia was related to an effect on ischemic depolarization, we recorded cortical DC potential, electrocorticogram (ECoG) or EEG, and evoked potentials in rabbits subjected to either 3 or 5 min of complete ischemia."3.69Lidocaine delays cortical ischemic depolarization: relationship to electrophysiologic recovery and neuropathology. ( Ayad, M; Rubinstein, EH; Verity, MA, 1994)
"We examined the effect of subarachnoid administration of lidocaine on delayed neuronal damage due to forebrain ischemia in rats."3.69[Subarachnoid administration of lidocaine reduces delayed neuronal damage due to forebrain ischemia in rats]. ( Mizunuma, T; Ohta, S; Suzuki, M, 1996)
"The changes in the direct-current potential shift in the hippocampal CA1 area produced by transient forebrain ischemia for 4 min were compared in animals given lidocaine (0."3.69Lidocaine suppresses the anoxic depolarization and reduces the increase in the intracellular Ca2+ concentration in gerbil hippocampal neurons. ( Adachi, N; Arai, T; Kataoka, K; Liu, K; Yanase, H, 1997)
"Dogs were treated with repeated doses of lidocaine or equivalent volumes of saline during hyperbaric therapy after internal carotid air embolism and transient hypertension."3.68Effect of lidocaine on somatosensory evoked response and cerebral blood flow after canine cerebral air embolism. ( Clark, JB; Dutka, AJ; Hallenbeck, JM; McDermott, J; Mink, R, 1992)
"We examined the effect of lidocaine on ischemic neuronal injury in the rat forebrain ischemia model."3.67Effect of lidocaine on forebrain ischemia in rats. ( Louw, D; Ong, BY; Sima, AA; Sutherland, G, 1989)
"In patients with severe head trauma, endotracheal suctioning can result in adverse reactions including cough, systemic hypertension, increased intracranial pressure, and reduced cerebral perfusion pressure."1.35Endotracheal lidocaine in preventing endotracheal suctioning-induced changes in cerebral hemodynamics in patients with severe head trauma. ( Bilotta, F; Branca, G; Cuzzone, V; Doronzio, A; Lam, A; Rosa, G, 2008)
"Following middle cerebral artery occlusion, rats received intensive enriched-rehabilitation (ER) of the impaired forelimb for 4 weeks."1.33Bi-hemispheric contribution to functional motor recovery of the affected forelimb following focal ischemic brain injury in rats. ( Biernaskie, J; Corbett, D; Szymanska, A; Windle, V, 2005)
"Surgical preparation of focal cerebral ischemia models may alter leukocyte reactivity and thereby make interpretation of leukocyte function following ischemia/reperfusion difficult."1.29Polymorphonuclear leukocyte behavior in a nonhuman primate focal ischemia model. ( Copeland, BR; del Zoppo, GJ; Ember, JA; Hugli, TE; Mori, E; Thomas, WS, 1994)
"In complete global ischemia (cardiac arrest) reperfusion is characterized by an immediate reactive hyperemia followed within 20-30 min by a delayed hypoperfusion state."1.29[Cerebral protection]. ( Cattaneo, AD, 1993)
"The effects on the pressor response to cerebral ischemia (CIR) of superfusion of the ventral medullary surface with artificial cerebrospinal fluid (CSF) containing local anesthetic was investigated in 10 sinoaortic-denervated, anesthetized cats."1.27Mediation of pressor responses to cerebral ischemia by superficial ventral medullary areas. ( Polosa, C; Rohlicek, CV, 1983)
"Pretreatment with lidocaine also greatly attenuated the acute hypertension and the increase in intracranial pressure following air embolism."1.27Protective effect of lidocaine in acute cerebral ischemia induced by air embolism. ( Bradley, ME; Evans, DE; Kobrine, AI; LeGrys, DC, 1984)
"Cerebral ischemia was induced in dogs on cardiopulmonary bypass circulation by stopping the pump."1.26Increase in extracellular potassium in the brain during circulatory arrest: effects of hypothermia, lidocaine, and thiopental. ( Astrup, J; Gjerris, F; Skovsted, P; Sørensen, HR, 1981)

Research

Studies (49)

TimeframeStudies, this research(%)All Research%
pre-199018 (36.73)18.7374
1990's17 (34.69)18.2507
2000's9 (18.37)29.6817
2010's5 (10.20)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wright, JL1
Durieux, ME1
Groves, DS1
Mitchell, SJ1
Merry, AF1
Armogida, M1
Giustizieri, M1
Zona, C1
Piccirilli, S1
Nisticò, R1
Mercuri, NB1
Xie, JD1
Wang, DF1
Cao, H1
Li, J3
Wang, J1
Duan, SM1
Zeng, YM1
Melinek, J1
Hart, AP1
Wix-Ramos, R1
Eblen-Zajjur, A1
Jennekens, W1
Dankers, F1
Janssen, F1
Toet, M1
van der Aa, N1
Niemarkt, H1
van Pul, C1
de Vries, L1
Andriessen, P1
Lei, B2
Popp, S1
Capuano-Waters, C1
Cottrell, JE2
Kass, IS2
Lim, YJ1
Huang, Y1
Fang, H1
Zuo, Z1
WAHAL, PK1
MATHUR, KS1
Biernaskie, J1
Szymanska, A1
Windle, V1
Corbett, D1
Seyfried, FJ1
Adachi, N3
Arai, T4
Bilotta, F1
Branca, G1
Lam, A1
Cuzzone, V1
Doronzio, A1
Rosa, G1
Astrup, J4
Fitch, W1
Gelb, AW3
Rohlicek, CV1
Polosa, C1
Evans, DE3
Kobrine, AI3
LeGrys, DC1
Bradley, ME1
Sørensen, HR3
Skovsted, P1
Gjerris, F1
Sørensen, PM1
Fujitani, T1
Miyazaki, H1
Liu, K2
Nakamura, Y1
Kataoka, K2
Weber, ML1
Taylor, CP1
Ember, JA1
del Zoppo, GJ1
Mori, E1
Thomas, WS1
Copeland, BR1
Hugli, TE1
Ayad, M1
Verity, MA1
Rubinstein, EH1
Cattaneo, AD1
Mizunuma, T1
Ohta, S1
Suzuki, M1
Yanase, H1
Yamauchi, Y1
Kotani, J1
Ueda, Y1
Wang, D2
Wu, X2
Zhong, Y1
Zhou, Y2
Shan, G2
Hu, X2
Liu, Y2
Qin, X2
Xia, Z2
Kim, DC1
Todd, MM1
Wang, G1
Dutka, AJ1
Mink, R1
McDermott, J1
Clark, JB1
Hallenbeck, JM1
Koegler, SM1
Seidler, FJ1
Spencer, JR1
Slotkin, TA1
Artru, F1
Terrier, A1
Tixier, S1
Jourdan, C1
Deleuze, R1
Gao, CR1
Shokunbi, MT1
Wu, XM1
Miller, DJ1
Ahlemeyer, B1
Krieglstein, J1
Prabhakar, NR1
Mitra, J1
Van de Graaff, W1
Haxhiu, MA1
Cherniack, NS1
Catron, PW1
McDermott, JJ1
Thomas, LB1
Flynn, ET1
Sutherland, G1
Ong, BY1
Louw, D1
Sima, AA1
Ma, SS1
Steinberg, GK1
Lam, AM1
Manninen, PH1
Peerless, SJ1
Rassi-Neto, A1
Warner, DS1
Godersky, JC1
Smith, ML1
Heuser, D1
Guggenberger, H1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effectiveness of Add-on Inhibitory Repetitive Transcranial Magnetic Stimulation Over the Contralesional Primary Motor Cortex in Subacute Stroke Patients With Severe Upper Limb Motor Impairment[NCT05505201]24 participants (Anticipated)Interventional2022-11-11Recruiting
The Effect of Retrobulbar Block on Bi-Hemispheric Cerebral Oxygen Saturation and Early Period Postoperative Cognitive Functions With Lidocaine and Levobupivacaine in Elderly Patients With Ophthalmic Surgery[NCT03189329]Phase 466 participants (Actual)Interventional2015-01-31Completed
Lidocaine For Neuroprotection During Cardiac Surgery[NCT00938964]550 participants (Actual)Interventional2009-07-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Change in Center for Epidemiological Studies Depression Scale (CES-D)

"Center for Epidemiological Studies Depression Scale (CES-D). The CES-D is a 20-item self-report examination designed to measure symptoms of depression. Subjects rate the degree to which they have experienced a range of symptoms of depression, such as I had crying spells and I felt lonely. Scores range from 0 to 60, with higher scores indicating greater depressive symptoms. Scores greater than 16 are typically considered indicative of clinically significant depression." (NCT00938964)
Timeframe: baseline, 1-year

Interventionunits on a scale (Mean)
Lidocaine-1.27
Placebo-0.89

Change in Center for Epidemiological Studies Depression Scale (CES-D)

"Center for Epidemiological Studies Depression Scale (CES-D). The CES-D is a 20-item self-report examination designed to measure symptoms of depression. Subjects rate the degree to which they have experienced a range of symptoms of depression, such as I had crying spells and I felt lonely. Scores range from 0 to 60, with higher scores indicating greater depressive symptoms. Scores greater than 16 are typically considered indicative of clinically significant depression." (NCT00938964)
Timeframe: baseline, 6-weeks

Interventionunits on a scale (Mean)
Lidocaine0.57
Placebo0.16

Change in Cognitive Function From Baseline

To characterize cognitive function over time, while minimizing potential redundancy in the cognitive measures, a factor analysis was performed on the 14 cognitive test scores from baseline. We chose a five-factor solution, which represents 5 cognitive domains: structured verbal memory, unstructured verbal memory, executive function, visual memory and attention/concentration. To quantify overall cognitive function, a baseline cognitive index was first calculated as the mean of the 5 preoperative domain scores. The cognitive index score has a mean of zero, thus any positive score is above the mean, any negative score is below the mean. A continuous change score was then calculated by subtracting the baseline from the 1 year cognitive index. The resulting outcome measure is unbounded with standard deviation of 0.35. A negative change score indicating decline and a positive score indicating improvement (NCT00938964)
Timeframe: 1 year after surgery

Interventionunits on a scale (Mean)
Lidocaine0.09
Placebo0.07

Change in Cognitive Function From Baseline Characterized as Continuous Cognitive Change

To characterize cognitive function over time, while minimizing potential redundancy in the cognitive measures, a factor analysis was performed on the 14 cognitive test scores from baseline. We chose a five-factor solution, which represents 5 cognitive domains: structured verbal memory, unstructured verbal memory, executive function, visual memory and attention/concentration. To quantify overall cognitive function, a baseline cognitive index was first calculated as the mean of the 5 preoperative domain scores. The cognitive index score has a mean of zero, thus any positive score is above the mean, any negative score is below the mean. A continuous change score was then calculated by subtracting the baseline from the 6-week cognitive index. The resulting outcome measure is unbounded with standard deviation of 0.35. A negative change score indicating decline and a positive score indicating improvement. (NCT00938964)
Timeframe: Preoperative to 6 weeks after surgery

Interventionunits on a scale (Mean)
Lidocaine0.07
Placebo0.07

Change in Duke Activity Status Index (DASI)

"The DASI is a 12-item scale of functional capacity that has been found to correlate well with objective measures of maximal exercise capacity. Items reflect activities of personal care, ambulation, household tasks, sexual function, and recreational activities. Activities done with no difficulty receive scores, which are weighted and summed, for a quantitative measure of functional status. Scores range from 0 to 60; a higher-weighted score indicates better function." (NCT00938964)
Timeframe: baseline, 1-year

Interventionunits on a scale (Mean)
Lidocaine6.3
Placebo6.96

Change in Duke Activity Status Index (DASI)

"The DASI is a 12-item scale of functional capacity that has been found to correlate well with objective measures of maximal exercise capacity. Items reflect activities of personal care, ambulation, household tasks, sexual function, and recreational activities. Activities done with no difficulty receive scores, which are weighted and summed, for a quantitative measure of functional status. Scores range from 0 to 60; a higher-weighted score indicates better function." (NCT00938964)
Timeframe: baseline, 6-weeks

Interventionunits on a scale (Mean)
Lidocaine-10.98
Placebo-11.67

Change in Neurological Function, as Measured by the National Institutes of Health Stroke Scale (NIHSS)

The National Institutes of Health Stroke Scale (NIHSS) is a 15-item neurologic examination stroke scale used to evaluate the effect of acute cerebral infarction on the levels of consciousness, language, neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and sensory loss. A trained observer rates the patent's ability to answer questions and perform activities. Ratings for each item are scored with 3 to 5 grades with 0 as normal, and there is an allowance for untestable items. The range of scores is from 0 (normal) to 42 (profound effect of stroke on patient). (NCT00938964)
Timeframe: baseline, 1-year

Interventionunits on a scale (Mean)
Lidocaine0.05
Placebo0.07

Change in Neurological Function, as Measured by the National Institutes of Health Stroke Scale (NIHSS)

The National Institutes of Health Stroke Scale (NIHSS) is a 15-item neurologic examination stroke scale used to evaluate the effect of acute cerebral infarction on the levels of consciousness, language, neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and sensory loss. A trained observer rates the patent's ability to answer questions and perform activities. Ratings for each item are scored with 3 to 5 grades with 0 as normal, and there is an allowance for untestable items. The range of scores is from 0 (normal) to 42 (profound effect of stroke on patient). (NCT00938964)
Timeframe: baseline, 6-weeks

Interventionunits on a scale (Mean)
Lidocaine0.05
Placebo0.04

Change in Neurological Function, as Measured by the Western Perioperative Neurologic Scale (WPNS)

The Western perioperative neurologic scale was designed to detect neurologic deficits after cardiac surgery. It includes 14 items classified into eight domains (mentation, speech, cranial nerve function, motor weakness, sensation and cerebellum, reflexes, and gait). Each item is scored from 0 (severe deficit) to3 (normal), and a maximum score of 42 indicates normal neurological function. (NCT00938964)
Timeframe: baseline, 1-year

Interventionunits on a scale (Mean)
Lidocaine0.02
Placebo-0.02

Change in Neurological Function, as Measured by the Western Perioperative Neurologic Scale (WPNS)

The Western perioperative neurologic scale was designed to detect neurologic deficits after cardiac surgery. It includes 14 items classified into eight domains (mentation, speech, cranial nerve function, motor weakness, sensation and cerebellum, reflexes, and gait). Each item is scored from 0 (severe deficit) to3 (normal), and a maximum score of 42 indicates normal neurological function. (NCT00938964)
Timeframe: baseline, 6-weeks

Interventionunits on a scale (Mean)
Lidocaine0.04
Placebo-0.01

Change in Perceived Social Support

"Perceived Social Support Scale: Twelve items indicate how strongly subjects agree that there is a special person who is around when I am in need and my family really tries to help me. Choices range from very strongly disagree to very strongly agree. Items are summed for a range of 12 to 84, with a high score meaning more social support." (NCT00938964)
Timeframe: baseline, 1-year

Interventionunits on a scale (Mean)
Lidocaine0.71
Placebo-1.16

Change in Perceived Social Support

"Perceived Social Support Scale: Twelve items indicate how strongly subjects agree that there is a special person who is around when I am in need and my family really tries to help me. Choices range from very strongly disagree to very strongly agree. Items are summed for a range of 12 to 84, with a high score meaning more social support." (NCT00938964)
Timeframe: baseline, 6-weeks

Interventionunits on a scale (Mean)
Lidocaine1.23
Placebo-0.49

Change in Social Activity

"Social Activity: This measure consisted of eight items that indicate the degree of social interaction. Sample items are How often do you talk on the telephone with friends and relatives? and How often do you attend meetings of social groups, clubs, or civic organizations? Scores range from 8 to 32. A lower score indicates more social activity." (NCT00938964)
Timeframe: baseline, 1-year

Interventionunits on a scale (Mean)
Lidocaine-0.20
Placebo0.03

Change in Social Activity

"Social Activity: This measure consisted of eight items that indicate the degree of social interaction. Sample items are How often do you talk on the telephone with friends and relatives? and How often do you attend meetings of social groups, clubs, or civic organizations? Scores range from 8 to 32. A lower score indicates more social activity." (NCT00938964)
Timeframe: baseline, 6-weeks

Interventionunits on a scale (Mean)
Lidocaine0.95
Placebo1.59

Change in Spielberger State Anxiety Inventory (STAI)

"Spielberger State Anxiety Inventory (STAI): The STAI consists of two 20-item scales that measure anxiety. Representative items include statements such as I feel nervous and I feel worried. These items are rated on a 4-point scale, based on how well they describe the patient's current or typical mood, from not at all to very much so. Scores range from 20 to 80, with higher scores indicating greater anxiety." (NCT00938964)
Timeframe: baseline, 1-year

Interventionunits on a scale (Mean)
Lidocaine-6.70
Placebo-6.39

Change in Spielberger State Anxiety Inventory (STAI)

"Spielberger State Anxiety Inventory (STAI): The STAI consists of two 20-item scales that measure anxiety. Representative items include statements such as I feel nervous and I feel worried. These items are rated on a 4-point scale, based on how well they describe the patient's current or typical mood, from not at all to very much so. Scores range from 20 to 80, with higher scores indicating greater anxiety." (NCT00938964)
Timeframe: baseline, 6-weeks

Interventionunits on a scale (Mean)
Lidocaine-7.12
Placebo-6.31

Change in Symptom Limitations

Symptom limitations: Patients were given a list of eight symptoms and asked to rate the degree to which the symptom limited daily activities. The symptoms were angina, shortness of breath, arthritis, back trouble, leg pains, headaches, fatigue, and other. Scores range from 8 to 32, with higher scores indicating greater limitations. (NCT00938964)
Timeframe: baseline, 1-year

Interventionunits on a scale (Mean)
Lidocaine-1.39
Placebo-1.48

Change in Symptom Limitations

Symptom limitations: Patients were given a list of eight symptoms and asked to rate the degree to which the symptom limited daily activities. The symptoms were angina, shortness of breath, arthritis, back trouble, leg pains, headaches, fatigue, and other. Scores range from 8 to 32, with higher scores indicating greater limitations. (NCT00938964)
Timeframe: baseline, 6-weeks

Interventionunits on a scale (Mean)
Lidocaine-0.67
Placebo-0.8

Change in the Cognitive Difficulties Scale

"Cognitive Difficulties Scale: a 39-item scale, is a self-report assessment of perceived problems in long- and short-term memory, concentration, attention, and psycho-motor coordination. Sample items are I forget errands I planned to do and I fail to recognize people I know. Scores range from 39 to 164, with higher scores indicating greater cognitive difficulty." (NCT00938964)
Timeframe: baseline, 1-year

Interventionunits on a scale (Mean)
Lidocaine-0.46
Placebo-1.02

Change in the Cognitive Difficulties Scale

"Cognitive Difficulties Scale: a 39-item scale, is a self-report assessment of perceived problems in long- and short-term memory, concentration, attention, and psycho-motor coordination. Sample items are I forget errands I planned to do and I fail to recognize people I know. Scores range from 39 to 164, with higher scores indicating greater cognitive difficulty." (NCT00938964)
Timeframe: baseline, 6-weeks

Interventionunits on a scale (Mean)
Lidocaine-3
Placebo-3.21

Change in the Duke Older Americans Resources and Services Procedures- Instrumental Activities of Daily Living (OARS-IADL)

"Duke Older Americans Resources and Services Procedures- Instrumental Activities of Daily Living (OARS-IADL): This measure contains six items that assess the ability to perform important tasks for daily living (e.g., Could you prepare your own meals? Could you drive a car?). Scores range from 6 to 24. Higher scores indicate increasing difficulty in engaging in daily activities." (NCT00938964)
Timeframe: baseline, 1-year

Interventionunits on a scale (Mean)
Lidocaine-0.15
Placebo-0.31

Change in the Duke Older Americans Resources and Services Procedures- Instrumental Activities of Daily Living (OARS-IADL)

"Duke Older Americans Resources and Services Procedures- Instrumental Activities of Daily Living (OARS-IADL): This measure contains six items that assess the ability to perform important tasks for daily living (e.g., Could you prepare your own meals? Could you drive a car?). Scores range from 6 to 24. Higher scores indicate increasing difficulty in engaging in daily activities." (NCT00938964)
Timeframe: baseline, 6-weeks

Interventionunits on a scale (Mean)
Lidocaine2.46
Placebo2.1

Count of Participants With a Decline of Greater Than or Equal to One Standard Deviation in One or More of Five Cognitive Domain Scores Reported as a Dichotomous Post-operative Cognitive Deficit (POCD) Outcome

To characterize cognitive function over time, while minimizing potential redundancy in the cognitive measures, a factor analysis was performed on the 14 cognitive test scores from baseline. We chose a five-factor solution, which represents 5 cognitive domains: structured verbal memory, unstructured verbal memory, executive function, visual memory and attention/concentration. Each domain score is normally distributed with a mean of zero. A change score was calculated for each domain by subtracting the baseline from the 6-week score. A dichotomous outcome variable of post-operative cognitive deficit was defined as a decline of ≥1 standard deviation in 1 or more of the 5 domains. (NCT00938964)
Timeframe: Preoperative to 6 weeks after surgery

InterventionParticipants (Count of Participants)
Lidocaine87
Placebo83

Change in Study 36-Item Short Form Health Survey (SF-36)

The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36): The SF-36 was designed to measure general health status. Two scales were used: Work Activities (four items) and General Health (one item). For the work activities scale, the reported score was the sum of four questions, each with values ranging from 1 to 4, the total score could range from 4 to 16. A higher score on Work Activities indicates more health-related problems For the general health question, the patients ranked their health from Excellent (1) to poor (5), the scale ranged from 1 to 5 with 1 being best health and 5 being worst. A high score in General Health indicates poorer health state. (NCT00938964)
Timeframe: baseline, 1-year

,
Interventionunits on a scale (Mean)
1 year Change Work Activities1 year Change General health perception
Lidocaine-1.37-0.28
Placebo-1.42-0.43

Change in Study 36-Item Short Form Health Survey (SF-36)

The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36): The SF-36 was designed to measure general health status. Two scales were used: Work Activities (four items) and General Health (one item). For the work activities scale, the reported score was the sum of four questions, each with values ranging from 1 to 4, the total score could range from 4 to 16. A higher score on Work Activities indicates more health-related problems For the general health question, the patients ranked their health from Excellent (1) to poor (5), the scale ranged from 1 to 5 with 1 being best health and 5 being worst. A high score in General Health indicates poorer health state. (NCT00938964)
Timeframe: baseline, 6-weeks

,
Interventionunits on a scale (Mean)
6-Week Change Work activities6-Week Change General health perception
Lidocaine2.71-0.004
Placebo3-0.03

Transcerebral Activation Gradient of Platelet-neutrophil Conjugates

Paired jugular venous and radial arterial blood samples were drawn at baseline, cross-clamp removal, end of cardiopulmonary bypass, and 6 hours post cross-clamp removalime points and analyzed by fluorescence-activated cell sorting to identify activated platelets. Transcerebral activation gradients were calculated by subtracting arterial values from venous values and were compared between groups (NCT00938964)
Timeframe: Baseline to 6 hours post cross-clamp removal

,
InterventionMean linear fluorescence intensity-MLFI (Mean)
BaselineCross-clamp removalEnd of Bypass6 hours post cross-clamp removal
Lidocaine-0.150.02-0.73-0.10
Placebo-0.43-0.73-0.400.19

Transcerebral Activation Gradients of Monocytes

Paired jugular venous and radial arterial blood samples were drawn at baseline, cross-clamp removal, end of cardiopulmonary bypass, and 6 hours post cross-clamp removalime points and analyzed by fluorescence-activated cell sorting to identify activated platelets. Transcerebral activation gradients were calculated by subtracting arterial values from venous values and were compared between groups (NCT00938964)
Timeframe: Baseline to 6 hours post cross-clamp removal

,
InterventionMean linear fluorescence intensity-MLFI (Mean)
BaselineCross-clamp removalEnd of Bypass6 hours post cross-clamp removal
Lidocaine-4.22-2.46-0.341.21
Placebo-0.041.832.640.54

Transcerebral Activation Gradients of Neutrophils

Paired jugular venous and radial arterial blood samples were drawn at baseline, cross-clamp removal, end of cardiopulmonary bypass, and 6 hours post cross-clamp removal and analyzed by fluorescence-activated cell sorting to identify activated platelets. Transcerebral activation gradients were calculated by subtracting arterial values from venous values and were compared between groups (NCT00938964)
Timeframe: Baseline to 6 hours post cross-clamp removal

,
InterventionMean linear fluorescence intensity-MLFI (Mean)
BaselineCross-clamp removalEnd of Bypass6 hours post cross-clamp removal
Lidocaine-2.020.560.581.04
Placebo-0.080.171.19-0.68

Transcerebral Activation Gradients of Platelets

Paired jugular venous and radial arterial blood samples were drawn at baseline, cross-clamp removal, end of cardiopulmonary bypass, and 6 hours post cross-clamp removalime points and analyzed by fluorescence-activated cell sorting to identify activated platelets. Transcerebral activation gradients were calculated by subtracting arterial values from venous values and were compared between groups (NCT00938964)
Timeframe: Baseline to 6 hours post cross-clamp removal

,
InterventionMean linear fluorescence intensity-MLFI (Mean)
BaselineCross-clamp removalEnd of Bypass6 hours post cross-clamp removal
Lidocaine-0.030.030.330.37
Placebo0.350.430.050.27

Reviews

6 reviews available for lidocaine and Cerebral Ischemia

ArticleYear
A brief review of innovative uses for local anesthetics.
    Current opinion in anaesthesiology, 2008, Volume: 21, Issue:5

    Topics: Anesthetics, Local; Animals; Brain Ischemia; Decompression Sickness; Dose-Response Relationship, Dru

2008
Lignocaine: neuro-protective or wishful thinking?
    The journal of extra-corporeal technology, 2009, Volume: 41, Issue:1

    Topics: Anesthetics, Local; Anti-Arrhythmia Agents; Brain Ischemia; Cardiopulmonary Bypass; Evidence-Based M

2009
Energy-requiring cell functions in the ischemic brain. Their critical supply and possible inhibition in protective therapy.
    Journal of neurosurgery, 1982, Volume: 56, Issue:4

    Topics: Animals; Barbiturates; Brain; Brain Ischemia; Cell Membrane Permeability; Cerebral Infarction; Cereb

1982
Physiology of the cerebral circulation and current thoughts on the protection of the brain against ischemia.
    International anesthesiology clinics, 1984,Fall, Volume: 22, Issue:3

    Topics: Animals; Barbiturates; Blood Pressure; Brain Ischemia; Carotid Artery Diseases; Carotid Artery, Inte

1984
[Brain resuscitation].
    Masui. The Japanese journal of anesthesiology, 1996, Volume: 45 Suppl

    Topics: Barbital; Brain; Brain Ischemia; Excitatory Amino Acid Antagonists; Humans; Hypothermia, Induced; Li

1996
Ionic changes in brain ischaemia and alterations produced by drugs.
    British journal of anaesthesia, 1985, Volume: 57, Issue:1

    Topics: Animals; Biological Transport, Active; Brain Ischemia; Calcium; Calcium Channel Blockers; Cats; Extr

1985

Other Studies

43 other studies available for lidocaine and Cerebral Ischemia

ArticleYear
N-ethyl lidocaine (QX-314) protects striatal neurons against ischemia: an in vitro electrophysiological study.
    Synapse (New York, N.Y.), 2010, Volume: 64, Issue:2

    Topics: Animals; Brain Ischemia; Cell Hypoxia; Cerebral Cortex; Dose-Response Relationship, Drug; Glucose; I

2010
[A study of the protective effects of lidocaine and nerve growth factor pretreatment on cerebral ischemia/reperfusion injury in gerbils].
    Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue, 2010, Volume: 22, Issue:4

    Topics: Animals; Apoptosis; Brain Ischemia; Disease Models, Animal; Gerbillinae; Ischemic Preconditioning; L

2010
[Effects of lidocaine and thiopental on the neuronal injury in rat hippocampus slice cultures].
    Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 2003, Volume: 19, Issue:3

    Topics: Animals; Brain Ischemia; CA1 Region, Hippocampal; In Vitro Techniques; Lidocaine; Neurons; Rats; Thi

2003
Vertebral artery dissection complicating occipital injection of heparin for treatment of thoracic outlet syndrome.
    The American journal of forensic medicine and pathology, 2012, Volume: 33, Issue:1

    Topics: Adult; Anesthetics, Local; Anticoagulants; Brain; Brain Ischemia; Female; Forensic Pathology; Heart

2012
Time course of acute neuroprotective effects of lidocaine evaluated by brain impedanciometry in the global ischemia model.
    Pharmacology, 2011, Volume: 88, Issue:5-6

    Topics: Animals; Brain; Brain Edema; Brain Ischemia; Disease Models, Animal; Electric Impedance; Lidocaine;

2011
Effects of midazolam and lidocaine on spectral properties of the EEG in full-term neonates with stroke.
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2012, Volume: 16, Issue:6

    Topics: Anticonvulsants; Brain Ischemia; Data Interpretation, Statistical; Electroencephalography; Epilepsy;

2012
Effects of delayed administration of low-dose lidocaine on transient focal cerebral ischemia in rats.
    Anesthesiology, 2002, Volume: 97, Issue:6

    Topics: Animals; Anti-Arrhythmia Agents; Brain Ischemia; Cerebrovascular Circulation; Dose-Response Relation

2002
Effects of local and intravenous anesthetics on the activity of glutamate transporter type 2.
    Brain research bulletin, 2003, Sep-30, Volume: 61, Issue:5

    Topics: Anesthetics, Intravenous; Anesthetics, Local; Animals; Brain Ischemia; Bupivacaine; Cell Membrane; E

2003
IMMEDIATE TREATMENT OF OCCLUSIVE CEREBROVASCULAR DISEASE--A COMPARATIVE EVALUATION OF DIFFERENT REGIMES OF TREATMENT.
    The Journal of the Association of Physicians of India, 1963, Volume: 11

    Topics: Adrenocorticotropic Hormone; Anesthesia; Anesthesia, Conduction; Anesthesia, Spinal; Anticoagulants;

1963
Bi-hemispheric contribution to functional motor recovery of the affected forelimb following focal ischemic brain injury in rats.
    The European journal of neuroscience, 2005, Volume: 21, Issue:4

    Topics: Animals; Behavior, Animal; Brain Infarction; Brain Ischemia; Forelimb; Functional Laterality; Infarc

2005
Suppression of energy requirement by lidocaine in the ischemic mouse brain.
    Journal of neurosurgical anesthesiology, 2005, Volume: 17, Issue:2

    Topics: Acidosis; Acidosis, Lactic; Adenosine Diphosphate; Adenosine Triphosphate; Anaerobiosis; Anesthetics

2005
Endotracheal lidocaine in preventing endotracheal suctioning-induced changes in cerebral hemodynamics in patients with severe head trauma.
    Neurocritical care, 2008, Volume: 8, Issue:2

    Topics: Adult; Brain Ischemia; Cerebrovascular Circulation; Craniocerebral Trauma; Female; Glasgow Coma Scal

2008
Anesthetic considerations for carotid endarterectomy.
    International anesthesiology clinics, 1984,Fall, Volume: 22, Issue:3

    Topics: Aged; Anesthesia, General; Anesthesia, Inhalation; Blood Pressure; Brain; Brain Ischemia; Carbon Dio

1984
Mediation of pressor responses to cerebral ischemia by superficial ventral medullary areas.
    The American journal of physiology, 1983, Volume: 245, Issue:6

    Topics: Animals; Aorta; Blood Pressure; Brain Ischemia; Carotid Arteries; Carotid Sinus; Cats; Cerebrovascul

1983
Protective effect of lidocaine in acute cerebral ischemia induced by air embolism.
    Journal of neurosurgery, 1984, Volume: 60, Issue:2

    Topics: Acute Disease; Animals; Brain; Brain Ischemia; Cats; Embolism, Air; Evoked Potentials, Somatosensory

1984
Inhibition of cerebral metabolism by lidocaine.
    European neurology, 1981, Volume: 20, Issue:3

    Topics: Animals; Brain; Brain Ischemia; Cell Membrane Permeability; Dogs; Electroencephalography; Glucose; L

1981
Increase in extracellular potassium in the brain during circulatory arrest: effects of hypothermia, lidocaine, and thiopental.
    Anesthesiology, 1981, Volume: 55, Issue:3

    Topics: Animals; Brain; Brain Ischemia; Cardiopulmonary Bypass; Cell Membrane Permeability; Dogs; Hypothermi

1981
Inhibition of cerebral oxygen and glucose consumption in the dog by hypothermia, pentobarbital, and lidocaine.
    Anesthesiology, 1981, Volume: 55, Issue:3

    Topics: Animals; Brain Ischemia; Cardiopulmonary Bypass; Dogs; Glucose; Hypothermia, Induced; Lidocaine; Oxy

1981
Lidocaine protects hippocampal neurons against ischemic damage by preventing increase of extracellular excitatory amino acids: a microdialysis study in Mongolian gerbils.
    Neuroscience letters, 1994, Sep-26, Volume: 179, Issue:1-2

    Topics: Animals; Brain Ischemia; Excitatory Amino Acids; Gerbillinae; Hippocampus; Lidocaine; Male; Microdia

1994
Damage from oxygen and glucose deprivation in hippocampal slices is prevented by tetrodotoxin, lidocaine and phenytoin without blockade of action potentials.
    Brain research, 1994, Nov-21, Volume: 664, Issue:1-2

    Topics: Action Potentials; Animals; Brain Ischemia; Evoked Potentials; Hippocampus; Hypoxia, Brain; In Vitro

1994
Polymorphonuclear leukocyte behavior in a nonhuman primate focal ischemia model.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1994, Volume: 14, Issue:6

    Topics: Animals; Brain Ischemia; Chemotaxis, Leukocyte; Complement C5a; Dose-Response Relationship, Drug; Le

1994
Lidocaine delays cortical ischemic depolarization: relationship to electrophysiologic recovery and neuropathology.
    Journal of neurosurgical anesthesiology, 1994, Volume: 6, Issue:2

    Topics: Animals; Brain; Brain Ischemia; Cerebral Cortex; Electrophysiology; Lidocaine; Male; Rabbits

1994
[Cerebral protection].
    Minerva anestesiologica, 1993, Volume: 59, Issue:9

    Topics: Adrenal Cortex Hormones; Anesthetics; Barbiturates; Benzodiazepines; Brain Ischemia; Calcium Channel

1993
[Subarachnoid administration of lidocaine reduces delayed neuronal damage due to forebrain ischemia in rats].
    Masui. The Japanese journal of anesthesiology, 1996, Volume: 45, Issue:4

    Topics: Anesthetics, Local; Animals; Brain Ischemia; Cell Death; Lidocaine; Male; Neurons; Prosencephalon; R

1996
Lidocaine suppresses the anoxic depolarization and reduces the increase in the intracellular Ca2+ concentration in gerbil hippocampal neurons.
    Anesthesiology, 1997, Volume: 87, Issue:6

    Topics: Anesthetics, Local; Animals; Brain Ischemia; Calcium; Gerbillinae; Hemodynamics; Ion Transport; Lido

1997
The effects of exogenous epinephrine on a convulsive dose of lidocaine: relationship with cerebral circulation.
    Journal of neurosurgical anesthesiology, 1998, Volume: 10, Issue:3

    Topics: Adrenergic Agonists; Analysis of Variance; Anesthesia, General; Anesthetics, Local; Animals; Blood P

1998
Effect of lidocaine on improving cerebral protection provided by retrograde cerebral perfusion: a neuropathologic study.
    Journal of cardiothoracic and vascular anesthesia, 1999, Volume: 13, Issue:2

    Topics: Anesthetics, Local; Animals; Blood Glucose; Blood Pressure; Brain Ischemia; Cardiopulmonary Bypass;

1999
Forebrain ischemia: effect on pharmacologically induced seizure thresholds in the rat.
    Brain research, 1999, Jun-12, Volume: 831, Issue:1-2

    Topics: Analysis of Variance; Animals; Brain Ischemia; Convulsants; Lidocaine; Male; N-Methylaspartate; Pent

1999
Lidocaine improving the cerebral protection by retrograde cerebral perfusion.
    Chinese medical journal, 1998, Volume: 111, Issue:10

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Brain; Brain Ischemia; Cardiopulmonary Bypas

1998
Neuroprotective effect of low-dose lidocaine in a rat model of transient focal cerebral ischemia.
    Anesthesiology, 2001, Volume: 95, Issue:2

    Topics: Anesthetics, Local; Animals; Blood Gas Analysis; Body Weight; Brain Infarction; Brain Ischemia; Hemo

2001
Effect of lidocaine on somatosensory evoked response and cerebral blood flow after canine cerebral air embolism.
    Stroke, 1992, Volume: 23, Issue:10

    Topics: Animals; Blood Pressure; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Dogs;

1992
Ischemia contributes to adverse effects of cocaine on brain development: suppression of ornithine decarboxylase activity in neonatal rat.
    Brain research bulletin, 1991, Volume: 27, Issue:6

    Topics: Animals; Brain; Brain Ischemia; Cocaine; Injections, Intraventricular; Injections, Subcutaneous; Lid

1991
[Use of intravenous lidocaine in neuro-anesthesia and neuro-resuscitation].
    Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression, 1991, Volume: 32, Issue:8-9 Spec N

    Topics: Anesthesia, Intravenous; Brain Ischemia; Humans; Intracranial Pressure; Lidocaine; Neurosurgery; Pse

1991
[Cerebral protection in neurosurgical anesthesia].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 1991, Volume: 29, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthesia, General; Brain Ischemia; Brain Neoplasms; Ce

1991
Continuous lidocaine infusion and focal feline cerebral ischemia.
    Stroke, 1990, Volume: 21, Issue:1

    Topics: Animals; Brain Ischemia; Cats; Cerebral Infarction; Cerebrovascular Circulation; Evoked Potentials,

1990
Testing drug effects against hypoxic damage of cultured neurons during long-term recovery.
    Life sciences, 1989, Volume: 45, Issue:9

    Topics: Adenosine Triphosphate; Animals; Anticonvulsants; Brain Ischemia; Cell Count; Cell Survival; Cells,

1989
Effect of focal cooling of central chemosensitive areas on cerebral ischemic response.
    The American journal of physiology, 1986, Volume: 251, Issue:2 Pt 2

    Topics: Administration, Topical; Anesthesia, Local; Animals; Atropine; Blood Pressure; Brain; Brain Ischemia

1986
Effect of lidocaine after experimental cerebral ischemia induced by air embolism.
    Journal of neurosurgery, 1989, Volume: 70, Issue:1

    Topics: Animals; Blood Pressure; Brain Ischemia; Cats; Embolism, Air; Evoked Potentials, Somatosensory; Fema

1989
Effect of lidocaine on forebrain ischemia in rats.
    Stroke, 1989, Volume: 20, Issue:1

    Topics: Animals; Blood Pressure; Brain; Brain Ischemia; Diencephalon; Lidocaine; Male; Neurons; Rats; Rats,

1989
[Role of lidocaine in protecting central neurons from ischemic or anoxic damage].
    Zhonghua yi xue za zhi, 1986, Volume: 66, Issue:9

    Topics: Animals; Brain; Brain Ischemia; Hypoxia, Brain; Lidocaine; Rabbits

1986
The effects of a prophylactic bolus of lidocaine in focal cerebral ischaemia.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1988, Volume: 35, Issue:5

    Topics: Animals; Brain Ischemia; Cats; Evoked Potentials, Somatosensory; Injections, Intravenous; Lidocaine

1988
Failure of pre-ischemic lidocaine administration to ameliorate global ischemic brain damage in the rat.
    Anesthesiology, 1988, Volume: 68, Issue:1

    Topics: Animals; Brain; Brain Edema; Brain Ischemia; Lidocaine; Male; Necrosis; Premedication; Rats

1988
Reduction of experimental intracranial hypertension by lidocaine.
    Neurosurgery, 1987, Volume: 20, Issue:4

    Topics: Acute Disease; Animals; Blood Pressure; Brain Ischemia; Cats; Embolism, Air; Female; Infusions, Intr

1987